Article
Mutation-resolved single-cell transcriptomics reveals enhanced β-amyloid clearance in TET2-mutant human monocytes.
JCI insight - 24 Aug 2026
Yang Xiao, Fatima Sameen, Sampere-Birlanga Salvador, Ware Akshay, Shumliakivska Mariana, Zanders Lukas, Radhakrishnan Srisurekha, Luxán Guillermo, John David, Günther Stefan, Mas-Peiro Silvia, Dimmeler Stefanie, Zeiher Andreas M, Abplanalp Wesley T
Abstract excerpt
TET2-driven clonal hematopoiesis has been associated with reduced Alzheimer's disease risk, but mechanisms in humans remain unclear. Using mutation-resolved single-cell transcriptomics, we distinguished TET2-mutant and wild-type monocytes within the same aged individuals and identified enrichment of phagocytosis and complement programs in mutant cells. TET2 silencing in human monocytes and macrophages...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
